Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
2/28/2025 | 2/28/2024 | 2/28/2023 | 2/28/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $142,660 | $19,186,000 | $87,520 | $86,619 |
| Dep. & Amort. | $41,536 | $5,172,000 | $36,907 | $38,753 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$46,329 | -$1,227,000 | -$9,853 | $34,628 |
| Other Non-Cash | -$14,831 | -$4,943,000 | -$19,720 | $12,188 |
| Operating Cash Flow | $123,036 | $18,188,000 | $94,854 | $172,189 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$90,311 | -$13,036,000 | -$58,938 | -$37,605 |
| Net Acquisitions | $1,010 | -$6,800,000 | $7,483 | $332 |
| Inv. Purchases | -$3,350 | -$15,000 | -$141,345 | -$101,767 |
| Inv. Sales/Matur. | $207,793 | $1,552,000 | $14,898 | $21,883 |
| Other Inv. Act. | $13 | $15,787,000 | $15 | $27 |
| Investing Cash Flow | $115,154 | -$2,512,000 | -$177,887 | -$117,130 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $10,576 | -$70,000 | -$71,000 | -$117,000 |
| Stock Issued | $0 | $0 | -$15 | -$18 |
| Stock Repurch. | -$69,199 | -$9,796,000 | -$7,694,000 | -$8,043,000 |
| Dividends Paid | -$42,743 | -$6,578,000 | -$50,076 | -$61,336 |
| Other Fin. Act. | -$2,557 | -$247,000 | $7,705,615 | $8,085,112 |
| Financing Cash Flow | -$103,923 | -$16,691,000 | -$109,461 | -$136,224 |
| Forex Effect | $4,369 | $1,957,000 | -$76,040 | -$27,452 |
| Net Chg. in Cash | $138,636 | $942,000 | -$268,535 | -$108,618 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $360,266 | $65,424,000 | $748,834 | $857,453 |
| End Cash | $498,902 | $66,366,000 | $480,300 | $748,834 |
| Free Cash Flow | $33,688 | $5,152,000 | $35,916 | $134,583 |